ArticleThe journal of pathology. Clinical research2025

Immunohistochemistry-based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy.

Csilla Olah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.